Salvage therapy for relapsed or refractory diffuse large B-cell lymphoma: impact of prior rituximab

被引：19
|
作者：
Sud, Rohit [1 ]
Friedberg, Jonathan W. [1 ]
机构：
[1] Univ Rochester, Dept Med, James P Wilmot Canc Ctr, Rochester, NY 14627 USA
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2008年 / 93卷 / 12期
关键词：
D O I：
10.3324/haematol.2008.000984
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1776 / 1780
页数：5
相关论文
共 50 条
  • [1] Bendamustine/rituximab in relapsed or refractory diffuse large B-cell lymphoma
    Vacirca, J. L.
    Acs, P. I.
    Shimkus, B. J.
    Rosen, P. J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [2] Salvage therapy for relapsed/refractory diffuse large B cell lymphoma
    Sesbadri, Tara
    Kuruvilla, Fohn
    Crump, Michael
    Keating, Armand
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (03) : 259 - 267
  • [3] Efficacy of Salvage Radiotherapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma
    Wang, S.
    Chen, J. Y.
    Cao, W.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E471 - E472
  • [4] Efficacy of salvage radiotherapy for relapsed/refractory diffuse large B-cell lymphoma
    Wang, Shu-Bei
    Chen, Jia-Yi
    Zhao, Wei-Li
    Kirova, Youlia M.
    Cao, Wei-Guo
    [J]. TRANSLATIONAL CANCER RESEARCH, 2019, 8 (04) : 1019 - 1026
  • [5] Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: The ORCHARRD Study
    van Imhoff, Gustaaf W.
    McMillan, Andrew
    Matasar, Matthew J.
    Radford, John
    Ardeshna, Kirit M.
    Kuliczkowski, Kazimierz
    Kim, WonSeog
    Hong, Xiaonan
    Goerloev, Jette Soenderskov
    Davies, Andrew
    Caballero Barrigon, Maria Dolores
    Ogura, Michinori
    Leppa, Sirpa
    Fennessy, Michael
    Liao, Qiming
    van der Holt, Bronno
    Lisby, Steen
    Hagenbeek, Anton
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (05) : 544 - +
  • [6] Salvage therapy R-DAOx in patients with relapsed or refractory diffuse large B-CELL lymphoma
    Mappa, S.
    Rigacci, L.
    Nassi, L.
    Puccini, B.
    Alterini, R.
    Carrai, V.
    Bernardi, F.
    Bosi, A.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 532 - 532
  • [7] Relapsed/Refractory Diffuse Large B-Cell Lymphoma
    Friedberg, Jonathan W.
    [J]. HEMATOLOGY-AMERICAN SOCIETY HEMATOLOGY EDUCATION PROGRAM, 2011, : 498 - 505
  • [8] Zanubrutinib plus salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma
    Yuan, Xianggui
    Li, Xian
    Huang, Yurong
    Jin, Xueli
    Liu, Hui
    Zhao, Aiqi
    Zhang, Weiping
    Qian, Wenbin
    Liang, Yun
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [9] STATE OF SALVAGE THERAPY FOR RELAPSED AND PRIMARY REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA
    Moskowitz, Craig
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (01) : S28 - S29
  • [10] Modified R-DAOx as salvage therapy in patients with relapsed or refractory diffuse large B-cell lymphoma
    Rigacci, L.
    Fabbri, A.
    Mappa, S.
    Nassi, L.
    Lenoci, M.
    Puccini, B.
    Alterini, R.
    Chitarrelli, I
    Carrai, V
    Lauria, F.
    Bosi, A.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 61 - 61
12345